September 2, 2025

LifeStance Health Group, Inc. (LFST) Stock Analysis: Uncovering a 53% Upside Potential in the Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) is a notable player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Scottsdale, Arizona, the company has carved out..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unpacking the 19% Potential Upside in the Healthcare Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC) stands out in the healthcare sector, specifically in the medical devices industry, with its innovative solutions for spinal disorder treatments. Headquartered in Carlsbad, California, this..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: A Biotech Pioneer with a 46.53% Potential Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is carving a niche in the biotechnology sector by leveraging its innovative approach to drug development. Focused on small molecule therapeutics that utilize the body’s..

NovoCure Limited (NVCR): Investor Outlook on a Promising 120% Upside in Cancer Treatment Innovations

NovoCure Limited (NASDAQ: NVCR) finds itself at the intersection of innovation and investment opportunity within the healthcare sector. As a key player in the medical devices industry, NovoCure is dedicated..

Organon & Co. (OGN) Investor Outlook: Evaluating a 39.77% Potential Upside in a Volatile Market

Organon & Co. (NYSE: OGN) stands as a notable entity in the healthcare sector, specifically within the drug manufacturing industry. Headquartered in Jersey City, New Jersey, and with a market..

Premier, Inc. (PINC) Stock Analysis: Navigating Challenges with a 3.24% Dividend Yield

Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare sector, operates as a healthcare improvement company based in Charlotte, North Carolina. With a market capitalization of $2.14 billion, the..

Addus HomeCare Corporation (ADUS) Stock Analysis: Healthcare Growth with 22% Potential Upside

Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the healthcare sector, is drawing attention from investors due to its strong growth potential and favorable analyst ratings. With a market..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a Promising 18% Upside in Biotech

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stands out in the biotech industry with a promising blend of innovative therapeutics and robust market potential. Headquartered in Newark, California, this healthcare sector player..

QuidelOrtho Corporation (QDEL) Stock Analysis: Navigating a 50% Upside Potential Amidst Industry Challenges

QuidelOrtho Corporation (QDEL), a prominent player in the healthcare sector specializing in medical devices, has been capturing investor attention with its intriguing market dynamics and significant upside potential. With its..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Navigating the Biotech Landscape with a $3.54 Billion Market Cap

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) stands out in the biotechnology sector with its focus on developing treatments for rare diseases and cancers. The company, headquartered in Stamford, Connecticut, has carved..

Metsera, Inc. (MTSR) Stock Analysis: Analysts Predict a 67% Upside for This Biotech Innovator

Metsera, Inc. (NASDAQ: MTSR) is capturing the attention of investors with its impressive potential upside, as analysts project a 67.19% increase from its current trading price of $35.29. This clinical-stage..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unpacking the 228% Potential Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX) is capturing the attention of investors with its promising potential upside of 228.20%, according to recent analyst ratings. As a biotech company headquartered in San..

Apellis Pharmaceuticals (APLS) Investor Outlook: Analyzing the 39.85% Potential Upside

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stands out as a compelling opportunity in the biotechnology sector, offering a notable potential upside of 39.85% according to analyst ratings. As a commercial-stage biopharmaceutical..

Ultragenyx Pharmaceutical Inc. (RARE): Analyst Ratings Signal 187% Potential Upside for Investors

Ultragenyx Pharmaceutical Inc. (RARE), a trailblazer in the biotechnology sector, is focused on addressing rare and ultra-rare genetic diseases through its innovative biopharmaceutical solutions. Headquartered in Novato, California, this company..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating a 17.88% Potential Upside in the Dental Solutions Market

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with a notable 17.88% potential upside...

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: A 32.53% Upside Potential Amidst Robust Buy Ratings

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands out in the healthcare sector as a prominent provider of behavioral healthcare services across the United States and Puerto Rico. With a market..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 31% Potential Upside in the Diagnostics Sector

Veracyte, Inc. (NASDAQ: VCYT) is a noteworthy player within the healthcare sector, specializing in the diagnostics and research industry. With a market capitalization of $2.39 billion, this California-based company is..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 70% Potential Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biotechnology sector, is drawing significant attention from investors, thanks to its robust pipeline and exciting market potential. With a market..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: A 53% Potential Upside in Biotech

Scholar Rock Holding Corporation (NASDAQ: SRRK) presents a compelling opportunity for investors interested in the biotechnology sector. With its focus on developing innovative treatments for serious diseases, Scholar Rock has..

Privia Health Group, Inc. (PRVA) Stock Analysis: A Promising 30.86% Upside in the Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves within the healthcare sector as a key player in health information services. With a market capitalization of $2.83 billion, this Arlington,..

Search

Funds

September 2, 2025

Search

Funds

September 2, 2025

FTSE 100

Funds